Arcellx ACLX Stock
Arcellx Price Chart
Arcellx ACLX Financial and Trading Overview
| Arcellx stock price | 54.25 USD |
| Previous Close | 37.94 USD |
| Open | 37.78 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 36.46 - 38.12 USD |
| 52 Week Range | 14.64 - 48.92 USD |
| Volume | 738.92K USD |
| Avg. Volume | 563.86K USD |
| Market Cap | 1.78B USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.47 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.4 USD |
ACLX Valuation Measures
| Enterprise Value | 1.37B USD |
| Trailing P/E | N/A |
| Forward P/E | -11.948388 |
| PEG Ratio (5 yr expected) | -0.24 |
| Price/Sales (ttm) | 99.245155 |
| Price/Book (mrq) | 5.834909 |
| Enterprise Value/Revenue | 76.76 |
| Enterprise Value/EBITDA | -7.082 |
Trading Information
Arcellx Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 128.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 48.92 USD |
| 52 Week Low | 14.64 USD |
| 50-Day Moving Average | 39.7 USD |
| 200-Day Moving Average | 29.02 USD |
ACLX Share Statistics
| Avg. Volume (3 month) | 563.86K USD |
| Avg. Daily Volume (10-Days) | 608.06K USD |
| Shares Outstanding | 47.99M |
| Float | 31.49M |
| Short Ratio | 12.89 |
| % Held by Insiders | 15.43% |
| % Held by Institutions | 92.35% |
| Shares Short | 6.1M |
| Short % of Float | 14.38% |
| Short % of Shares Outstanding | 12.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1092.14% |
| Gross Margin | 92.14% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.10% |
| Return on Equity (ttm) | -71.46% |
Income Statement
| Revenue (ttm) | 17.91M USD |
| Revenue Per Share (ttm) | 0.42 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -194135008 USD |
| Net Income Avi to Common (ttm) | -189982000 USD |
| Diluted EPS (ttm) | -4.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 533.59M USD |
| Total Cash Per Share (mrq) | 11.12 USD |
| Total Debt (mrq) | 87.65M USD |
| Total Debt/Equity (mrq) | 28.86 USD |
| Current Ratio (mrq) | 3.441 |
| Book Value Per Share (mrq) | 6.348 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 115.33M USD |
| Levered Free Cash Flow (ttm) | -10082375 USD |
Profile of Arcellx
| Country | United States |
| State | MD |
| City | Gaithersburg |
| Address | 25 West Watkins Mill Road |
| ZIP | 20878 |
| Phone | 240 327 0630 |
| Website | https://arcellx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 98 |
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and product candidates for solid tumor programs. It has strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize CART-ddBCMA. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.
Q&A For Arcellx Stock
What is a current ACLX stock price?
Arcellx ACLX stock price today per share is 54.25 USD.
How to purchase Arcellx stock?
You can buy ACLX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Arcellx?
The stock symbol or ticker of Arcellx is ACLX.
Which industry does the Arcellx company belong to?
The Arcellx industry is Biotechnology.
How many shares does Arcellx have in circulation?
The max supply of Arcellx shares is 57.04M.
What is Arcellx Price to Earnings Ratio (PE Ratio)?
Arcellx PE Ratio is now.
What was Arcellx earnings per share over the trailing 12 months (TTM)?
Arcellx EPS is -1.47 USD over the trailing 12 months.
Which sector does the Arcellx company belong to?
The Arcellx sector is Healthcare.
Arcellx ACLX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}